CHIR Chiron (MM)

Chiron to Present at JPMorgan 22nd Annual Healthcare Conference EMERYVILLE, Calif., Jan. 6 /PRNewswire-FirstCall/ -- Chiron Corporation today announced that it will present at the JPMorgan 22nd Annual Healthcare Conference in San Francisco on Tuesday, January 13, at 12:30 p.m. EST. Investors may access a live audio webcast of the presentation at http://www.chiron.com/webcast. In order to register and download any necessary software, please log on 15 minutes early. About Chiron Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people's lives. The company has a strategic focus on cancer and infectious disease. Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop products from its platforms in proteins, small molecules and vaccines. The company commercializes its products through three business units: BioPharmaceuticals, Vaccines and Blood Testing. For more information about Chiron, visit the company's website at http://www.chiron.com/. DATASOURCE: Chiron Corporation CONTACT: Corporate Communications & Investor Relations, media +1-510- 923-6500; or investors +1-510-923-2300 Web site: http://www.chiron.com/

Copyright